Physician profile
Robert Bertellotti
NPI 1013120740
$1,781.58
in general payments reported to CMS, 2019-2025
13 companies · $729 in 2025
The $729 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2021: $19.11 · 2023: $418 · 2024: $392 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,131 · Long Term Medical Supply Or Device Loan: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,131.19 |
| Long Term Medical Supply Or Device Loan | $406.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $520.48 | 2025 | Cytal, Integra, Integra Dermal Regeneration Template |
| Avita Medical Americas, LLC | $334.25 | 2024-2025 | Recell, Permeaderm, Cohealyx |
| Access Pro Medical, LLC | $271.42 | 2023 | Matriderm |
| Urgo Medical North America, LLC | $212.13 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Polynovo North America LLC | $187.84 | 2019-2023 | |
| Smith+Nephew, INC. | $72.94 | 2019-2023 | Collagenase Santyl |
| Vericel Corporation | $53.40 | 2025 | Nexobrid |
| Portola Pharmaceuticals, LLC | $24.86 | 2019 | |
| Osiris Therapeutics INC. | $23.99 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.47 | 2019 | |
| Boston Scientific Corporation | $22.88 | 2019 | |
| Braintree Laboratories, INC. | $22.29 | 2019 | |
| Melinta Therapeutics, LLC | $11.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bertellotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.